Indole-3-carbinol induces apoptosis of chronic myelogenous leukemia cells through suppression of STAT5 and Akt signaling pathways
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Indole-3-carbinol induces apoptosis of chronic myelogenous leukemia cells through suppression of STAT5 and Akt signaling pathways
Authors
Keywords
-
Journal
TUMOR BIOLOGY
Volume 39, Issue 6, Pages 101042831770576
Publisher
SAGE Publications
Online
2017-06-20
DOI
10.1177/1010428317705768
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Radioactive 125I seeds inhibit cell growth and epithelial-mesenchymal transition in human glioblastoma multiforme via a ROS-mediated signaling pathway
- (2015) Yunhong Tian et al. BMC CANCER
- Indole-3-carbinol suppresses NF-κB activity and stimulates the p53 pathway in pre-B acute lymphoblastic leukemia cells
- (2015) Majid Safa et al. TUMOR BIOLOGY
- Inhibition of STAT5: A therapeutic option in BCR-ABL1-driven leukemia
- (2015) Angelika Berger et al. Oncotarget
- Targeting the JAK2-STAT5 pathway in CML
- (2014) P. Valent BLOOD
- Targeting Apoptosis Pathways in Cancer and Perspectives with Natural Compounds from Mother Nature
- (2014) F. M. Millimouno et al. Cancer Prevention Research
- Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy
- (2014) S. Bibi et al. HAEMATOLOGICA
- Dual roles of c-Myc in the regulation of hTERT gene
- (2014) Yuanjun Zhao et al. NUCLEIC ACIDS RESEARCH
- OSU-A9, an indole-3-carbinol derivative, induces cytotoxicity in acute myeloid leukemia through reactive oxygen species-mediated apoptosis
- (2013) Li-Yuan Bai et al. BIOCHEMICAL PHARMACOLOGY
- Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR–CML cell lines?
- (2013) Vivian M. Rumjanek et al. BIOSCIENCE REPORTS
- Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic target
- (2013) J G Harb et al. LEUKEMIA
- Inhibition of STAT Signalling in Bladder Cancer by Diindolylmethane - Relevance to Cell Adhesion, Migration and Proliferation
- (2012) Yiyang Sun et al. CURRENT CANCER DRUG TARGETS
- BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia
- (2012) Oliver Hantschel et al. Nature Chemical Biology
- Regulation of hTERT by BCR-ABL at multiple levels in K562 cells
- (2011) Juin Hsien Chai et al. BMC CANCER
- Down-regulation of Thanatos-associated protein 11 by BCR-ABL promotes CML cell proliferation through c-Myc expression
- (2011) Satoki Nakamura et al. INTERNATIONAL JOURNAL OF CANCER
- BAX/BCL-XL gene expression ratio inversely correlates with disease progression in chronic myeloid leukemia
- (2010) Mariana S. Gonzalez et al. BLOOD CELLS MOLECULES AND DISEASES
- Stat5 is indispensable for the maintenance ofbcr/abl-positive leukaemia
- (2010) Andrea Hoelbl et al. EMBO Molecular Medicine
- Activation of the p38 Map kinase pathway is essential for the antileukemic effects of dasatinib
- (2010) Disha Dumka et al. LEUKEMIA & LYMPHOMA
- Human telomerase activity regulation
- (2010) Aneta Wojtyla et al. MOLECULAR BIOLOGY REPORTS
- Indole-3-carbinol as a chemopreventive and anti-cancer agent
- (2008) Jing-Ru Weng et al. CANCER LETTERS
- Phospho-CRKL monitoring for the assessment of BCR-ABL activity in imatinib-resistant chronic myeloid leukemia or Ph+ acute lymphoblastic leukemia patients treated with nilotinib
- (2008) P. La Rosee et al. HAEMATOLOGICA
- Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors
- (2008) H Konig et al. LEUKEMIA
- A Review of the Clinical Efficacy and Safety of Cruciferous Vegetable Phytochemicals
- (2008) Deanna M. Minich et al. NUTRITION REVIEWS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started